Joanne L Maki, Age 613121 Smithonia Rd, Colbert, GA 30628

Joanne Maki Phones & Addresses

3121 Smithonia Rd, Colbert, GA 30628 (706) 788-2841

3221 Smithonia Rd, Colbert, GA 30628 (706) 788-2841

Madison, GA

Athens, GA

Oak Ridge, TN

Lexington, GA

Social networks

Joanne L Maki

Linkedin

Work

Company: Merial Position: Program manager

Emails

m***e@gmail.com

Industries

Pharmaceuticals

Mentions for Joanne L Maki

Resumes

Resumes

Joanne Maki Photo 1

Program Manager At Merial

Position:
Program Manager at Merial
Location:
Athens, Georgia Area
Industry:
Pharmaceuticals
Work:
Merial
Program Manager

Publications

Us Patents

Vaccination Of Skunks And/or Mongooses Against Rabies

US Patent:
2005028, Dec 22, 2005
Filed:
Jun 20, 2005
Appl. No.:
11/156829
Inventors:
Joanne Maki - Colbert GA,
International Classification:
F23J013/08
C12Q001/68
F23J013/06
A61K031/70
A01N043/04
A61K039/12
US Classification:
435006000, 454005000
Abstract:
The present invention relates to recombinant anti-rabies vaccines and the oral administration of such vaccines to skunks and/or mongooses. Advantageously, the anti-rabies vaccine may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene. The invention encompasses methods of vaccinating skunks and/or mongooses by administration of an anti-rabies vaccines which may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene.

Adjuvanted Rabies Vaccine With Improved Viscosity Profile

US Patent:
2012026, Oct 25, 2012
Filed:
Apr 20, 2012
Appl. No.:
13/451667
Inventors:
Joanne L. Maki - Colbert GA,
Tricia Lynn Fry - Fort Collins CO,
Jerome Cornelius Hurley - Fort Collins CO,
Lowell Allen Miller - Greeley CO,
International Classification:
A61K 39/205
A61P 31/14
A61K 39/00
US Classification:
4241991
Abstract:
The present invention relates to adjuvanted recombinant anti-rabies vaccines and the oral administration of such vaccines to raccoons and other wildlife. Advantageously, the anti-rabies vaccine may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene. The invention encompasses methods of vaccinating raccoons and other wildlife by administration of an anti-rabies vaccines which may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene, in combination with an adjuvant which increases both vaccine viscosity and efficacy. The invention provides effective oral recombinant vaccines used in oral rabies vaccination (ORV) programs for wildlife, effective at protecting raccoons, gray foxes, coyotes, and other animals.

Alvac Poxvirus-Rabies Compositions And Combination Compositions And Uses

US Patent:
5843456, Dec 1, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/486969
Inventors:
Enzo Paoletti - Delmar NY
Joanne Maki - Colbert GA
Assignee:
Virogenetics Corporation - Troy NY
International Classification:
A61K 39275
A61K 39295
A61K 39205
US Classification:
4241991
Abstract:
Attenuated recombinant viruses containing DNA encoding a rabies virus antigen in a "cocktail" or combination or multivalent compositions well as methods for making and using the compositions, expression products therefrom, and antibodies generated, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The compositions and products therefrom and antibodies generated have several preventive, therapeutic and diagnostic uses.

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. People Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by People Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.